|
1
|
Chen W, Zheng R, Zuo T, Zeng H, Zhang S
and He J: National cancer incidence and mortality in China, 2012.
Chin J Cancer Res. 28:1–11. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ng SC and Wong SH: Colorectal cancer
screening in Asia. Br Med Bull. 105:29–42. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Garborg K: Colorectal cancer screening.
Surg Clin North Am. 95:979–989. 2015. View Article : Google Scholar : PubMed/NCBI
Leung WK, Lau JY, Suen BY, Wong GL, Chow
DK, Lai LH, To KF, Yim CK, Lee ES, Tsoi KK, et al: Repeat-screening
colonoscopy 5 years after normal baseline-screening colonoscopy in
average-risk Chinese: A prospective study. Am J Gastroenterol.
104:2028–2034. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Soon MS, Kozarek RA, Ayub K, Soon A, Lin
TY and Lin OS: Screening colonoscopy in Chinese and Western
patients: A comparative study. Am J Gastroenterol. 100:2749–2755.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
National Cancer Institute's SEER
database.[EB/OL]. http://seer.cancer.gov/August 26–2016
|
|
7
|
Labianca R, Nordlinger B, Beretta GD,
Mosconi S, Mandalà M, Cervantes A and Arnold D; ESMO Guidelines
Working Group, : Early colon cancer: ESMO Clinical Practice
Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 24
Suppl 6:vi64–vi72. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Twelves C, Wong A, Nowacki MP, Abt M,
Burris H III, Carrato A, Cassidy J, Cervantes A, Fagerberg J,
Georgoulias V, et al: Capecitabine as adjuvant treatment for stage
III colon cancer. N Engl J Med. 352:2696–2704. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Murphy CC, Harlan LC, Lund JL, Lynch CF
and Geiger AM: Patterns of colorectal cancer care in the united
states: 1990–2010. J Natl Cancer Inst. 107:pii: djv1982015.
View Article : Google Scholar
|
|
10
|
Jeffery M, Hickey BE, Hider PN and See AM:
Follow-up strategies for patients treated for non-metastatic
colorectal cancer. Cochrane Database Syst Rev.
11:CD0022002016.PubMed/NCBI
|
|
11
|
Reinert T, Schøler LV, Thomsen R, Tobiasen
H, Vang S, Nordentoft I, Lamy P, Kannerup AS, Mortensen FV,
Stribolt K, et al: Analysis of circulating tumour DNA to monitor
disease burden following colorectal cancer surgery. Gut.
65:625–634. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pita-Fernández S, Alhayek-Aí M,
González-Martín C, López-Calviño B, Seoane-Pillado T and
Pértega-Díaz S: Intensive follow-up strategies improve outcomes in
non-metastatic colorectal cancer patients after curative surgery: A
systematic review and meta-analysis. Ann Oncol. 26:644–656. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kraus S, Nabiochtchikov I, Shapira S and
Arber N: Recent advances in personalized colorectal cancer
research. Cancer Lett. 347:15–21. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu Z, Zhang Y, Niu Y, Li K, Liu X, Chen H
and Gao C: A systematic review and meta-analysis of diagnostic and
prognostic serum biomarkers of colorectal cancer. PLoS One.
9:e1039102014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chao M and Gibbs P: Caution is required
before recommending routine carcinoembryonic antigen and imaging
follow-up for patients with early-stage colon cancer. J Clin Oncol.
27:e279–280. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bettegowda C, Sausen M, Leary RJ, Kinde I,
Wang Y, Agrawal N, Bartlett BR, Wang H, Luber B, Alani RM, et al:
Detection of circulating tumor DNA in early- and late-stage human
malignancies. Sci Transl Med. 6:224ra242014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Butler TM, Johnson-camacho K, Peto M, Wang
NJ, Macey TA, Korkola JE, Koppie TM, Corless CL, Gray JW and
Spellman PT: Exome sequencing of cell-free DNA from metastatic
cancer patients identifies clinically actionable mutations distinct
from primary disease. PLoS One. 10:e01364072015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Husain H and Velculescu VE: Cancer DNA in
the circulation: The liquid biopsy. Jama. 318:1272–1274. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Roschewski M, Dunleavy K, Pittaluga S,
Moorhead M, Pepin F, Kong K, Shovlin M, Jaffe ES, Staudt LM, Lai C,
et al: Circulating tumour DNA and CT monitoring in patients with
untreated diffuse large B-cell lymphoma: A correlative biomarker
study. Lancet Oncol. 16:5412015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu S, Lou F, Wu Y, Sun DQ, Zhang JB, Chen
W, Ye H, Liu JH, Wei S, Zhao MY, et al: Circulating tumor DNA
identified by targeted sequencing in advanced-stage non-small cell
lung cancer patients. Cancer Lett. 370:324–331. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Diehl F, Schmidt K, Choti MA, Romans K,
Goodman S, Li M, Thornton K, Agrawal N, Sokoll L, Szabo SA, et al:
Circulating mutant DNA to assess tumor dynamics. Nat Med.
14:985–990. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tie J, Kinde I, Wang Y, Wong HL, Roebert
J, Christie M, Tacey M, Wong R, Singh M, Karapetis CS, et al:
Circulating tumor DNA as an early marker of therapeutic response in
patients with metastatic colorectal cancer. Ann Oncol.
26:1715–1722. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Stefanie Mortimer: Early, molecular
detection of cancer utilizing circulating cell-free DNA assay with
ultra high accuracy and sensitivity. ASCO. 2016.
|
|
24
|
Zhou J, Chang L, Guan Y, Yang L, Xia X,
Cui L, Yi X and Lin G: Application of circulating tumor DNA as a
non-invasive tool for monitoring the progression of colorectal
cancer. PLoS One. 11:e01597082016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Perdomo S, Anantharaman D, Mckay J and
Brennan P: Abstract 5230: Circulating tumor DNA as a ‘liquid
biopsy’ in head and neck cancer. Cancer Res. 75:5230. 2015.
View Article : Google Scholar
|
|
26
|
Aravanis AM, Lee M and Klausner RD:
Next-generation sequencing of circulating tumor DNA for early
cancer detection. Cell. 168:571–574. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tie J, Wang Y, Kinde I, Steel M, Elsaleh
H, Singh MS, Singh MS, Turner NH, Tran B, Strausberg R, et al:
Circulating tumor DNA (ctDNA) in nonmetastatic colorectal cancer
(CRC): Potential role as a screening tool. J Clin Oncol.
3:5182017.
|
|
28
|
Morgans A and Allen F: Getting ethics
committee approval for research: A beginners guide. Australasian J
Paramedicine. 3:2015.
|
|
29
|
Li H and Durbin R: Fast and accurate
long-read alignment with Burrows-Wheeler transform. Bioinformatics.
26:589–595. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li H, Handsaker B, Wysoker A, Fennell T,
Ruan J, Homer N, Marth G, Abecasis G and Durbin R: 1000 Genome
Project Data Processing Subgroup: The sequence alignment/map (SAM)
format and SAMtools. Bioinformatics. 25:2078–2079. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Koboldt DC, Zhang Q, Larson DE, Shen D,
McLellan MD, Lin L, Miller C, Mardis ER, Ding L and Wilson RK:
VarScan 2: Somatic mutation and copy number alteration discovery in
cancer by exome sequencing. Genome Res. 22:568–576. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
R: A Language and Environment for
Statistical Computing, R Core Team. R Foundation for Statistical
Computing; Vienna, Austria: https://www.R-project.org
|
|
33
|
Hari DM, Leung AM, Lee JH, Sim MS, Vuong
B, Chiu CG and Bilchik AJ: AJCC Cancer Staging Manual 7th edition
criteria for colon cancer: Do the complex modifications improve
prognostic assessment? J Am Coll Surg. 217:181–190. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sausen M, Phallen J, Adleff V, Jones S,
Leary RJ, Barrett MT, Anagnostou V, Parpart-Li S, Murphy D, Kay Li
Q, et al: Clinical implications of genomic alterations in the
tumour and circulation of pancreatic cancer patients. Nat Commun.
6:76862015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Dawson SJ, Tsui DW, Murtaza M, Biggs H,
Rueda OM, Chin SF, Dunning MJ, Gale D, Forshew T, Mahler-Araujo B,
et al: Analysis of circulating tumor DNA to monitor metastatic
breast cancer. N Engl J Med. 368:1199–1209. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Smith G, Carey FA, Beattie J, Wilkie MJ,
Lightfoot TJ, Coxhead J, Garner RC, Steele RJ and Wolf CR:
Mutations in APC, Kirsten-ras and p53-alternative genetic pathways
to colorectal cancer. Proc Natl Acad Sci USA. 99:pp. 9433–9488.
2002; View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tie J, Wang Y, Tomasetti C, Li L, Springer
S, Kinde I, Silliman N, Tacey M, Wong HL, Christie M, et al:
Circulating tumor DNA analysis detects minimal residual disease and
predicts recurrence in patients with stage II colon cancer. Sci
Transl Med. 8:346ra922016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Meyerhardt JA and Mayer RJ: Systemic
therapy for colorectal cancer. N Engl J Med. 352:476–487. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Schmitt MW, Kennedy SR, Salk JJ, Fox EJ,
Hiatt JB and Loeb LA: Detection of ultra-rare mutations by
next-generation sequencing. Proc Natl Acad Sci USA. 109:pp.
14508–14113. 2012; View Article : Google Scholar : PubMed/NCBI
|
